(Pharmamar) PharmaMar will receive an upfront payment of 5,000,000 US dollars, followed by development milestones if an antibody-drug conjugate enters clinical development.
Mayo Clinic will offer the Zika virus antibody test developed by the Centers for Disease Control and Prevention (CDC).This test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and has ...
Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
The model of an antibody conjugate required 85,000 Legos, mostly green ones.
(Reuters) - Immunomedics Inc said it entered into a licensing deal for its cancer treatment with Seattle Genetics Inc for a potential payment of up to about $2 billion.